# Dong-A Pharmaceutical signs exclusive supply deal with Neuain for migraine relief device

Dong-A Pharmaceutical signed an exclusive domestic supply agreement with Neuain on June 13, 2023, for a migraine relief medical device. The wearable device, which received FDA 510K and CE-MDD certification, will be exclusively sold by Dong-A in South Korea.

- Type: Contract
- Announced: 2023-06-14
- Where: Seoul, South Korea, South Korea
- Status: announced
- Products: migraine relief medical device (wearable neurostimulation device)
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Dong-A Pharmaceutical](https://endata.com/companies/70818.md) (customer)
- [Neuain](https://endata.com/companies/70819.md) (supplier)

## Sources

- [newswire.co.kr](https://www.newswire.co.kr/newsRead.php?no=968688), 2023-06-14: "동아제약은 13일 서울 동대문구 용두동 동아제약 본사에서, 전자약 연구개발 전문 기업 뉴아인과 편두통 완화 의료기기의 국내 독점 판매 공급 계약을 체결했다."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.